Jeantet advises investment funds Orbimed and Jeito Capital in connection with a EUR 65 million financing of Corteria Pharmaceuticals
Paris, September 8, 2023 – Jeantet has advised investment funds OrbiMed and Jeito Capital in connection with the series A financing of French biopharmaceutical company Corteria Pharmceuticals. Corteria Pharmaceuticals, a biopharmaceutical company specializing in the development of transformative therapies for heart failure subpopulations, announced on September 7, 2023 a EUR 65 million series A financing, […]
Paris | CORPORATE – M&A – PRIVATE EQUITY